Osmotica Kereskedelmi es Szolgaltato Korlatolt Felelossegu Tarsasag

Patent Applications and Registrations

Patent applications and USPTO patent grants for Osmotica Kereskedelmi es Szolgaltato Korlatolt Felelossegu Tarsasag.The latest application filed is for "composition and method for treating neurological disease".

Company Profile

0.10.9

Osmotica Kereskedelmi es Szolgaltato Korlatolt Felelossegu Tarsasag - Budapest HU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition And Method For Treating Neurological Disease App 20210353559 - MEYER; Glenn A. ; et al.	2021-11-18
Composition And Method For Treating Neurological Disease App 20210353558 - MEYER; Glenn A. ; et al.	2021-11-18
Composition And Method For Treating Neurological Disease App 20200129454 - MEYER; Glenn A. ; et al.	2020-04-30
Composition and method for treating neurological disease Grant 10,512,617 - Meyer , et al. Dec	2019-12-24
Composition and method for treating neurological disease Grant 10,500,172 - Meyer , et al. Dec	2019-12-10
Composition and method for treating neurological disease Grant 10,500,171 - Meyer , et al. Dec	2019-12-10
Composition and method for treating neurological disease Grant 10,500,170 - Meyer , et al. Dec	2019-12-10
Composition And Method For Treating Neurological Disease App 20190247330 - MEYER; Glenn A. ; et al.	2019-08-15
Composition And Method For Treating Neurological Disease App 20190247327 - MEYER; Glenn A. ; et al.	2019-08-15
Composition And Method For Treating Neurological Disease App 20190247328 - MEYER; Glenn A. ; et al.	2019-08-15
Composition And Method For Treating Neurological Disease App 20190247329 - MEYER; Glenn A. ; et al.	2019-08-15
Composition And Method For Treating Neurological Disease App 20190247331 - MEYER; Glenn A. ; et al.	2019-08-15
Composition and method for treating neurological disease Grant 10,213,394 - Meyer , et al. Feb	2019-02-26
Composition and method for treating neurological disease Grant 10,213,393 - Meyer , et al. Feb	2019-02-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.